ABIONYX Pharma SA (609) Q2 2023 Earnings Report
DE:609 Q2 2023 EPS Results
- Actual EPS
- -EUR 0.08
- Consensus EPS
- ―
- Beat/Miss
- ―
- One Year Ago EPS
- -EUR 0.09
DE:609 Q2 2023 Revenue Results
- Actual Revenue
- EUR 2.13M
- Expected Revenue
- EUR 2.10M
- Beat/Miss
- Beat by +EUR 28.00K
- YoY Revenue Growth
- -19.09%
Earnings Announcement Details
- Quarter
- Q2 2023
- Date
- 09/26/2023
- Time
- During Market Hours
- Conference Call
- Tuesday, September 26, 2023
DE:609 Upcoming Earnings
ABIONYX Pharma SA's next earnings date is estimated for March 16, 2027, based on past reporting schedules.
Q2 2023 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q2 2023 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2023 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:609 Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Mar 16, 2027 | 2026 (Q4) | ―- | -0.09 | ― | ― |
| Sep 23, 2026 | 2026 (Q2) | ―-0.13 | -0.07 | -103.03% (-0.07) | |
| Mar 12, 2026 | 2025 (Q4) | ―-0.09 | -0.07 | -40.00% (-0.03) | |
| Sep 25, 2025 | 2025 (Q2) | ―-0.07 | -0.06 | -3.13% (-0.00) | |
| Mar 05, 2025 | 2024 (Q4) | ―-0.07 | -0.04 | -62.50% (-0.03) | |
| Sep 26, 2024 | 2024 (Q2) | ―-0.06 | -0.08 | 17.95% (+0.01) | |
| Mar 11, 2024 | 2023 (Q4) | ―-0.04 | -0.06 | 31.03% (+0.02) | |
| Sep 26, 2023 | 2023 (Q2) | ―-0.08 | -0.09 | 14.29% (+0.01) | |
| Mar 29, 2023 | 2022 (Q4) | ―-0.06 | -0.13 | 54.69% (+0.07) | |
| Sep 29, 2022 | 2022 (Q2) | ―-0.09 | -0.1 | 7.14% (+0.01) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
